News & Analysis on Clinical Trial Services & Contract Research And Development
Pharma giant AstraZeneca last week announced its intention to cut 3,000 jobs in an effort to increase productivity and reduce costs. The company is the latest big pharma to trim its workforce as the industry readjusts in a more challenging environment.
A new inhaler with a child-friendly design aims to solve the problem of dosage variance and patient compliance - key issues with inhaled drug treatments for children.
A UK-based firm is offering advice to chemical and pharmaceutical companies on reducing hazardous waste and adhering to the Registration, Evaluation and Authorisation of Chemicals Regulation (REACH), which becomes law on 1 June 2007.
In the light of the death of former Russian security agent, Alexander Litvinenko, pharma companies developing anti-radiation drugs are increasingly under the spotlight.
As SR Pharma and Quark Biotech start clinical trials of a drug that uses a Nobel Prize winning technique to 'silence' disease-causing genes, the largest pharma firms are keen to grab a piece of the action.
US-based biopharmaceutical product providers Millipore has met its revenue and earnings target over the fiscal year, helped by its Serologicals acquisition in the fourth quarter and a solid performance by its main business driver: lab waters.
US-based Rockwell Automation has acquired Irish engineering firm ProsCon Holdings in a strategy to move into the European pharmaceutical market.
Bridge Pharmaceuticals has just launched a new training scheme between its facilities in the US and China to enable its employees to cross train in both labs - a potential competitive advantage for a contract research organisation (CRO).